Published in Scand J Immunol on December 01, 1992
Paratuberculosis. Clin Microbiol Rev (1994) 2.58
Isolation and sequencing of the gene coding for an antigenic 34-kilodalton protein of Mycobacterium paratuberculosis. J Bacteriol (1993) 1.18
Cloning and expression of portions of the 34-kilodalton-protein gene of Mycobacterium paratuberculosis: its application to serological analysis of Johne's disease. J Clin Microbiol (1993) 1.17
Development of species-specific enzyme-linked immunosorbent assay for diagnosis of Johne's disease in cattle. J Clin Microbiol (1994) 1.11
Alkyl hydroperoxide reductases C and D are major antigens constitutively expressed by Mycobacterium avium subsp. paratuberculosis. Infect Immun (2000) 1.11
Detection of Mycobacterium avium subsp. paratuberculosis in infected tissues by new species-specific immunohistological procedures. Clin Diagn Lab Immunol (1998) 0.96
Immunological analysis of the components of the antigen complex A60 of Mycobacterium bovis BCG. Clin Diagn Lab Immunol (1994) 0.80
Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J Clin Microbiol (1995) 2.77
Antibiotics of the virginiamycin family, inhibitors which contain synergistic components. Microbiol Rev (1979) 2.65
Paratuberculosis. Clin Microbiol Rev (1994) 2.58
Identification of a single base change in ribosomal RNA leading to erythromycin resistance. J Biol Chem (1992) 1.54
Evidence for the involvement of different genospecies of Borrelia in the clinical outcome of Lyme disease in Belgium. Res Microbiol (1994) 1.43
Preparation of a specific RNA probe for detection of Mycobacterium paratuberculosis and diagnosis of Johne's disease. J Clin Microbiol (1993) 1.38
Composition and immunological properties of the protein fraction of A36, a major antigen complex of Mycobacterium paratuberculosis. Scand J Immunol (1992) 1.30
Isolation and sequencing of the gene coding for an antigenic 34-kilodalton protein of Mycobacterium paratuberculosis. J Bacteriol (1993) 1.18
Cloning and expression of portions of the 34-kilodalton-protein gene of Mycobacterium paratuberculosis: its application to serological analysis of Johne's disease. J Clin Microbiol (1993) 1.17
Comparative analysis of the genomes of intestinal spirochetes of human and animal origin. Infect Immun (1989) 1.14
Preparation and properties of antigen 60 from Mycobacterium bovis BCG. Clin Exp Immunol (1986) 1.13
Development of species-specific enzyme-linked immunosorbent assay for diagnosis of Johne's disease in cattle. J Clin Microbiol (1994) 1.11
Metabolism of macromolecules in bacteria treated with virginiamycin. J Gen Microbiol (1969) 1.08
Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes. J Biol Chem (1987) 1.04
The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes. J Antimicrob Chemother (1989) 1.04
Cross-reactivity of antigens from the cytoplasm and cell walls of some corynebacteria and mycobacteria. J Infect Dis (1985) 1.04
Mechanism of action of streptogramins and macrolides. Drugs (1996) 1.03
The role of rRNA bases in the interaction of peptidyltransferase inhibitors with bacterial ribosomes. J Biol Chem (1992) 0.97
Detection of Mycobacterium avium subsp. paratuberculosis in infected tissues by new species-specific immunohistological procedures. Clin Diagn Lab Immunol (1998) 0.96
A microanalytical procedure for determination of the base composition of DNA. Eur J Biochem (1985) 0.95
Interference of virginiamycin M with the initiation and the elongation of peptide chains in cell-free systems. Biochim Biophys Acta (1974) 0.95
Duplex PCR for differential identification of Mycobacterium bovis, M. avium, and M. avium subsp. paratuberculosis in formalin- fixed paraffin-embedded tissues from cattle. J Clin Microbiol (2000) 0.94
Mycobacterial proliferation in macrophages is prevented by incubation with lymphocytes activated in vitro with a mycobacterial antigen complex. Eur J Immunol (1991) 0.94
Immunization of mice with the antigen A60 of Mycobacterium bovis BCG. Clin Exp Immunol (1992) 0.92
Mycobacterial antigen complex A60-specific T-cell repertoire during the course of pulmonary tuberculosis. Infect Immun (1993) 0.90
Definitive evidence for the actual contribution of yeast in the transformation of neutral precursors of grape aromas. J Agric Food Chem (2001) 0.90
Chemical composition of antigen 60 from Mycobacterium bovis BCG. Scand J Immunol (1986) 0.90
Virginiamycin M, a specific inhibitor of the acceptor site of ribosomes. Biochimie (1971) 0.90
Immunological properties of antigen 60 of BCG. Induction of humoral and cellular immune reactions. Scand J Immunol (1987) 0.89
Immunological relatedness of ribosomes from mycobacteria, nocardiae and corynebacteria, and microorganisms in leprosy lesions. Infect Immun (1978) 0.89
Biological, chemical, immunological and staining properties of bacteria isolated from tissues of leprosy patients. Eur J Epidemiol (1985) 0.88
Formation of chloroplast ribosomes and ribosomal RNA in Euglena incubated with protein inhibitors. Exp Cell Res (1973) 0.88
Thermostable macromolecular antigens from mycobacteria. Can J Microbiol (1994) 0.87
Structure and function of cytoplasmic organelles in transiently and permanently bleached Euglena. Exp Cell Res (1973) 0.87
Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M. Proc Natl Acad Sci U S A (1980) 0.87
Occurrence, in Crohn's disease, of antibodies directed against a species-specific recombinant polypeptide of Mycobacterium paratuberculosis. Clin Diagn Lab Immunol (1994) 0.86
A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes. Mol Gen Genet (1978) 0.86
The properties of virginiamycin-resistant mutants of Bacillus subtilis. J Gen Microbiol (1973) 0.86
Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic. Biochim Biophys Acta (1989) 0.85
Formation and decay of polyribosomes and ribosomes during the inhibition of protein synthesis and recovery. Biochimie (1971) 0.85
Affinity labeling of the virginiamycin S binding site on bacterial ribosome. Biochemistry (1990) 0.85
Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems. Biochim Biophys Acta (1988) 0.85
Pressure dissociation of bacterial ribosomes and reassociation of ribosomal subunits. Mol Gen Genet (1978) 0.85
Isolation and characterization of a novel glucuronosyl diacylglycerol from Mycobacterium smegmatis. Biochim Biophys Acta (1993) 0.84
Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes. J Biol Chem (1983) 0.84
The lasting ribosome alteration produced by virginiamycin M disappears upon removal of certain ribosomal proteins. Biochim Biophys Acta (1983) 0.84
Identification of a salvage pathway for D-arabinose in Mycobacterium smegmatis. Eur J Biochem (1988) 0.83
Formation of ribosomal particles in virginiamycin sensitive and resistant mutants of Bacillus subtilis. Biochimie (1973) 0.83
Molecular mechanism of action of virginiamycin-like antibiotics (synergimycins) on protein synthesis in bacterial cell-free systems. J Antimicrob Chemother (1985) 0.83
The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits. Mol Gen Genet (1978) 0.83
Serological analysis of pulmonary and extrapulmonary tuberculosis with enzyme-linked immunosorbent assays for anti-A60 immunoglobulins. Clin Infect Dis (1994) 0.82
The ribosomal cycle in bacteria treated with an inhibitor of protein synthesis. Biochimie (1973) 0.82
The action of virginiamycin on nucleic acid and protein synthesis in Bacillus subtilis infected with bacteriophage 2C. J Gen Microbiol (1969) 0.82
Intrathecal synthesis of anti-mycobacterial antibodies in patients with tuberculous meningitis. An immunoblotting study. J Neurol Neurosurg Psychiatry (1990) 0.82
Inhibition of polypeptide synthesis in cell-free systems by virginiamycin S and erythromycin. Evidence for a common mode of action of type B synergimycins and 14-membered macrolides. Biochim Biophys Acta (1988) 0.82
Saccharomyces cerevisiae cell fatty acid composition and release during fermentation without aeration and in absence of exogenous lipids. Int J Food Microbiol (1999) 0.82
Comparative analysis of three sensitins used in cutaneous testing for tuberculosis and paratuberculosis in cattle. FEMS Microbiol Lett (1993) 0.82
Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain. Nucleic Acids Res (1994) 0.82
Properties of microorganisms isolated from human leprosy lesions. Rev Infect Dis (1983) 0.82
Origin and metabolic properties of the RNA species formed during the replication cycle of virus 2C. J Virol (1974) 0.82
Analysis of fluorescence quenching of ribosome-bound virginiamycin S. J Biol Chem (1984) 0.81
Delayed hypersensitivity reactions by the mycobacterial antigen A60 and cutaneous testing in tuberculosis. Med Microbiol Immunol (1989) 0.81
Serological analysis of human tuberculosis by an ELISA with mycobacterial antigen 60. Scand J Infect Dis (1990) 0.81
DNA methylation in leprosy-associated bacteria: Mycobacterium leprae and Corynebacterium tuberculostearicum. Med Microbiol Immunol (1988) 0.81
Structure of the wall polysaccharide isolated from a group of corynebacteria. Eur J Biochem (1982) 0.81
Analysis of mycolic acids from a group of corynebacteria by capillary gas chromatography and mass spectrometry. Eur J Biochem (1982) 0.80
Prolongation of canine kidney-homograft survival by heterologous ribonucleic acid (RNA) perfusion. Br J Surg (1969) 0.80
Macromolecule metabolism and photosynthetic functions in blue-green algae treated with virginiamycin, an inhibitor of protein synthesis. Antimicrob Agents Chemother (1974) 0.80
Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit. Biochim Biophys Acta (1981) 0.80
Chemical identification of some cell-wall components of microorganisms isolated from human leprosy lesions. Zentralbl Bakteriol Mikrobiol Hyg A (1981) 0.80
Immunological analysis of the components of the antigen complex A60 of Mycobacterium bovis BCG. Clin Diagn Lab Immunol (1994) 0.80
Meabolism of nucleic acids in uninfected fibroblasts incubated in vitro with rat interferon. Life Sci (1965) 0.79
Comparison of the cytoplasmic antigens of leprosy-derived corynebacteria and some mycobacteria. Scand J Immunol (1983) 0.78
Size and homology of the genomes of leprosy-derived corynebacteria, Mycobacterium leprae, and other corynebacteria and mycobacteria. J Med Microbiol (1988) 0.78
Physical map of phage 2 C DNA: evidence for the existence of large redundant ends. Eur J Biochem (1983) 0.78
Effect of virginiamycin on the growth cycle of Bdellovibrio. Antimicrob Agents Chemother (1976) 0.78
Cloning and sequencing of a species-specific nucleotide fragment of Borrelia burgdorferi sensu stricto, which is repeated in several plasmids of the species. FEMS Microbiol Lett (1997) 0.78
Cyclotron production of carrier-free 66Ga as a positron emitting label of albumin colloids for clinical use. Eur J Nucl Med (1988) 0.77
Composition and immunogenicity of the polysaccharide components of the thermostable macromolecular antigen group of mycobacterial antigens. Med Microbiol Immunol (1992) 0.77
Interaction between virginiamycin S and ribosomes is partly provided by a salt bridge with a Mg2+ ion. Biochemistry (1991) 0.77
Comparison of the physical maps and redundant ends of the chromosomes of phages 2C, SP01, SP82 and phi e. Eur J Biochem (1983) 0.77
Ribosome protection by tRNA derivatives against inactivation by virginiamycin M: evidence for two types of interaction of tRNA with the donor site of peptidyl transferase. Biochemistry (1987) 0.77
Biochemical studies with leprosy-derived corynebacteria. Acta Leprol (1983) 0.77
Localization of virginiamycin S binding site on bacterial ribosome by fluorescence energy transfer. Biochemistry (1986) 0.76
Primary structure of the wall peptidoglycan of leprosy-derived corynebacteria. J Bacteriol (1981) 0.76
Inhibitory action of virginiamycin components on cell-free systems for polypeptide formation from Bacillus subtilis. Arch Microbiol (1983) 0.76
Recombinational-type transfer of viral DNA during bacteriophage 2C replication in Bacillus subtilis. J Virol (1976) 0.76